Navigation Links
Orphan Drug Market to Reach $112 Billion in 2017: Bcc Research
Date:7/16/2013

Wellesley, MA (PRWEB) July 16, 2013

In the new report, GLOBAL MARKETS FOR ORPHAN DRUGS (PHM038D), from BCC Research (http://www.bccresearch.com), the global market for orphan drugs was valued at $82.6 billion in 2011 and nearly $86 billion in 2012. The report forecasts total market value to reach $112 billion in 2017, after increasing at a five-year compound annual growth rate (CAGR) of 5.4%.

Orphan drugs are drugs that treat orphan diseases. An orphan disease is a disease that does not receive significant investment, research, or attention from the medical and pharmaceutical industries. Orphan diseases are most often rare diseases and are defined by using a ratio of incidence to population in the U.S., the EU, Japan and other developed countries. An orphan disease can also be a tropical disease whose typical sufferers cannot afford access to pharmaceutical treatment options.

Orphan diseases did not receive much attention from the pharmaceutical industry until the U.S. passed the first Orphan Drug Act in 1983. Other countries quickly began following suit with versions of the Orphan Drug Act. Before governments began passing these acts, the pharmaceutical industry could not make a profit from orphan drugs because of the small market size. Government intervention opened a path to profitability for pharmaceutical companies and created an interest to develop orphan drugs.

BCC Research’s Report analyzes the market for orphan drugs by region, by biological and non-biological drug type, by active ingredient, and by area of medical application. The report reveals why orphan drugs for oncology are the largest category for both biological and non-biological drugs. The report includes a detailed analysis of all other categories within biological and non-biological drugs.

This BCC Research report also provides a detailed explanation of the current market value, forecast, and growth rate for the next five years for both the biological and non-biological orphan drug segments. BCC Research valued the biological orphan drug segment at $57.7 billion in 2012, and expects the value to reach nearly $71.4 billion in 2017, registering a CAGR (compound annual growth rate) of 4.3%. The report valued non-biological orphan drugs at $28.3 billion in 2012, and forecasts the market to reach $40.8 billion in 2017, after growing at a CAGR (compound annual growth rate) of 7.5%.

Some of the growth drivers for the orphan drugs market discussed by BCC Research in the report include increased research and development, new technology, additional regulatory easing, and new product launches. Additionally, the ability of pharmaceutical companies to use orphan drugs for off-label uses is also helping in achieving market growth.

This BCC Research report provides insights into the regulations and laws that are allowing the orphan drugs market to grow. BCC Research’s report provides clear and precise guidance on every aspect of the industry.

The study will be beneficial to pharmaceutical and biotechnical companies, research institutes, and physicians.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10923141.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Ground Broken For New Orphanage In Africa Thanks To Living Fuel And FreeRide836 Kiteboarders
2. Tellurex Sends tPOD1™ to Light Up Orphanage in Uganda
3. FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa
4. 30 Years of Orphan Drug Act, Combined with Science and Advocacy, Reflect Dramatic Progress in a Rare Lung Disease, Pulmonary Hypertension Association Says
5. First Pathfinder Awards announced tackling rare and orphan diseases
6. Clinical Next Generation Sequencing Market: NGS Diagnostic 2018 Forecast in New Industry Research Report at ReportsnReports.com
7. Breast Pumps Market Is Expected to Reach USD 1.03 Billion Globally in 2018 : Transparency Market Research
8. Modular Data Center Market Is Expected to Reach $40.41 Billion by 2018 at a CAGR of 37.41% From 2013 to 2018 - New Report by MarketsandMarkets
9. SevenPoint2, the Alkaline Company, Is Finding a Marketing ‘Balance’ with CallFire’s Tele-pH-ony Solutions
10. Marshall Fong Joins FMC BioPolymer as Global Marketing Director of Food Ingredients
11. Pre-Harvest Market to Reach $55,696.6 Million by 2018 at a CAGR of 5.7% - New Report by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening to conquer ... in advanced audiology and hearing aid technology, has today ... world,s first internet connected hearing aid that opens up ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... , TwinLink™ - the first dual communication ...
(Date:6/23/2016)... , June 23, 2016 ... "Surgical Procedure Volumes: Global Analysis (United States, China, ... Canada)" report to their offering. ... essential tool for healthcare business planners, provides surgical procedure ... at surgery trends with an in-depth analysis of growth ...
(Date:6/23/2016)...  The National Pharmaceutical Council (NPC) today announced ... research organization as its newest member.  ... president and chief scientific officer, Mallinckrodt Pharmaceuticals, will ... Board of Directors. ... us in support of our efforts to conduct ...
Breaking Medicine Technology: